肠易激综合征的医疗利用模式及医疗补助计划的直接医疗净费用
Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome.
作者信息
Martin Bradley C, Ganguly Rahul, Pannicker Sandhya, Frech Feride, Barghout Victoria
机构信息
University of Georgia College of Pharmacy, Pharmacy Care Administration Graduate Program, Athens, Georgia 30602, USA.
出版信息
Curr Med Res Opin. 2003;19(8):771-80. doi: 10.1185/030079903125002540.
BACKGROUND
Patients with irritable bowel syndrome are frequent users of the health care system.
DESIGN AND METHODS
This retrospective matched case-control study assessed the economic impact of irritable bowel syndrome on the Medicaid program by comparing the health care utilization and expenditures of Medicaid patients with irritable bowel syndrome in California and North Carolina with age-, sex-, and race-matched control groups without the syndrome.
RESULTS
Average annual Medicaid expenditures per case of diagnosed irritable bowel syndrome were 2952 dollars and 5908 dollars in California and North Carolina, respectively; corresponding unadjusted net incremental expenditures were 962 dollars and 2191 dollars, respectively. In both states, patients with irritable bowel syndrome incurred greater costs than controls for physician visits, outpatient visits, and prescription drugs.
CONCLUSIONS
Irritable bowel syndrome was shown to impose an economic burden on the Medicaid program. The cost of treating patients with irritable bowel syndrome is higher than the cost of treating matched ambulatory Medicaid recipients without the condition.
背景
肠易激综合征患者频繁使用医疗保健系统。
设计与方法
这项回顾性配对病例对照研究通过比较加利福尼亚州和北卡罗来纳州患有肠易激综合征的医疗补助计划患者与年龄、性别和种族匹配的无该综合征对照组的医疗保健利用率和支出，评估了肠易激综合征对医疗补助计划的经济影响。
结果
在加利福尼亚州和北卡罗来纳州，每例确诊的肠易激综合征患者的平均年度医疗补助支出分别为2952美元和5908美元；相应的未经调整的净增量支出分别为962美元和2191美元。在这两个州，肠易激综合征患者在看医生、门诊就诊和处方药方面的费用均高于对照组。
结论
肠易激综合征被证明给医疗补助计划带来了经济负担。治疗肠易激综合征患者的成本高于治疗匹配的无该疾病的非卧床医疗补助接受者的成本。
Zotero 插件